Novel compounds

Details for Australian Patent Application No. 2005256470 (hide)

Owner Glaxo Group Limited

Inventors Borthwick, Alan David; Liddle, John; Mason, Andrew McMurtrie; Hickey, Deirdre Mary Bernadette

Agent Davies Collison Cave

Pub. Number AU-B-2005256470

PCT Pub. Number WO2006/000399

Priority 0414093.5 23.06.04 GB

Filing date 21 June 2005

Wipo publication date 5 January 2006

Acceptance publication date 2 February 2012

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/000399 Priority application(s): WO2006/000399

2 February 2012 Application Accepted

  Published as AU-B-2005256470

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005256471-Substituted diketopiperazines as oxytocin antagonists

2005256468-Novel use of peptide compounds for treating essential tremor and other tremor syndromes